PURE SEMINOMATOUS METASTATIC TESTICULAR-TUMORS - INDICATION FOR CHEMOTHERAPY

40% of testicular tumours are seminomatous tumours. The law mass tumou rs (LMT) (stages IIA and IIB of the Royal Mardsen Hospital classificat ion) are usually treated by radiotherapy and the high mass tumours (HM T) (stages IIC, III and IV) by chemotherapy. Chemotherapy regimens are platinum-based polychemotherapy. We report 9 cases of seminomatous te sticular tumours (4 LMT and 5 HMT) treated by chemotherapy (BEP modifi ed or CBDCTA-etoposide regimens), three courses, with one supplement c ourse if necessary and surgery if residual masses are more than 3 cm l ong. The rate of complete remission are 100% for LMT and 60% for HMT T his could be an indication to treat in addition with orchidectomy the LMT with chemotherapy and not with radiotherapy (standard-gold) which is more toxic.